The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 8,901–9,000 of 31,469
Horton, T. J., Dow, S., Armstrong, M., & Donahoo, W. T. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90812.2008 · Cited by 41
Mediating Effects of Inflammatory Biomarkers on Insulin Resistance Associated with Obesity
Wexler, D. J., Hu, F. B., Manson, J. E., Rifai, N., & Meigs, J. B. (2005) · Obesity Research · doi:10.1038/oby.2005.216 · Cited by 41
Yılmaz, M. İ., Sağlam, M., Sönmez, A., Çağlar, K., Çakır, E., Kurt, Y., Eyileten, T., Taşar, M., Açıkel, C., Oğuz, Y., et al. (2007) · Blood Purification · doi:10.1159/000107410 · Cited by 40
Effect of Gastric Bypass on Spontaneous Growth Hormone and Ghrelin Release Profiles
Mancini, M. C., da Costa, A. P. H., de Melo, M. E., Cercato, C., Giannella‐Neto, D., Junior, A. B. G., Rosberg, S., Albertsson-Wikland, K. G., Villares, S. M., & Halpern, A. (2006) · Obesity · doi:10.1038/oby.2006.51 · Cited by 41
Musa, C. V., Mancini, A., Alfieri, A., Labruna, G., Valerio, G., Franzese, A., Pasanisi, F., Licenziati, M. R., Sacchetti, L., & Buono, P. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.81 · Cited by 41
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
Hirshfeld‐Cytron, J., Barnes, R. B., Ehrmann, D. A., Caruso, A., Mortensen, M., & Rosenfield, R. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2248 · Cited by 41
Aloulou, I., Brun, J. ‐., & Mercier, J. G. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.002 · Cited by 45
Cholelithiasis, Cholecystectomy, and Liver Disease
Ioannou, G. N. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.737 · Cited by 41
Sprung, V. S., Jones, H., Pugh, C. J. A., Aziz, N., Daousi, C., Kemp, G. J., GREEN, D. J., Cable, N. T., & Cuthbertson, D. J. (2013) · Clinical Science · doi:10.1042/cs20130186 · Cited by 41
Fueki, Y., Miida, T., Wardaningsih, E., Ito, M., Nakamura, A., Takahashi, A., Hanyu, O., Tsuda, A., Saitō, H., Hama, H., et al. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.03.027 · Cited by 40
The Association of Plasma Lactate With Incident Cardiovascular Outcomes
Matsushita, K., Williams, E., Mongraw‐Chaffin, M., Coresh, J., Schmidt, M. I., Brancati, F. L., Hoogeveen, R. C., Ballantyne, C. M., & Young, J. H. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt002 · Cited by 42
Is epicardial fat tissue a marker of metabolic syndrome in obese children?
Mazur, A., Ostański, M., Telega, G. W., & Małecka‐Tendera, E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.036 · Cited by 41
Vegetables and PUFA‐rich plant oil reduce DNA strand breaks in individuals with type 2 diabetes
Müllner, E., Brath, H., Pleifer, S., Schiermayr, C., Baierl, A., Wallner, M., Fastian, T., Millner, Y., Paller, K., Henriksen, T., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200343 · Cited by 41
A cross-sectional study for glucose intolerance of myotonic dystrophy
Matsumura, T., Iwahashi, H., Funahashi, T., Takahashi, M. P., Saito, T., Yasui, K., Saito, T., Iyama, A., Toyooka, K., Fujimura, H., et al. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.037 · Cited by 41
Derosa, G., Maffioli, P., SALVADEO, S. A. T., Ferrari, I., Gravina, A., Mereu, R., D’Angelo, A., Palumbo, I., Randazzo, S., & Cicero, A. F. G. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.010 · Cited by 41
Uric acid: A surrogate of insulin resistance in older women
Chen, L., Lin, M.-H., Lai, H., Hwang, S., & Chiou, S.-T. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.10.006 · Cited by 41
Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats
Sadek, K. M., & Shaheen, H. M. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.854812 · Cited by 41
Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome
Santana, L. F., de Sá, M. F. S., Ferriani, R. A., Moura, M. D., Foss, M., & dos Reis, R. M. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400002342 · Cited by 42
Papoutsakis, C., Yannakoulia, M., Ντάλλα, Ι., & Dedoussis, G. V. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.006 · Cited by 41
Insulin resistance in treated HIV infection
Feeney, E. R., & Mallon, P. W. G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.11.002 · Cited by 45
Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus.
Chearskul, S., Sangurai, S., Nitiyanant, W., Kriengsinyos, W., Kooptiwut, S., & Harindhanavudhi, T. (2007) · PubMed · Cited by 41
Relationship between insulin resistance and accumulation of coronary risk factors
Ohnishi, H., Saitoh, S., Ura, N., Takagi, S., Obara, F., Akasaka, H., Oimatsu, H., & Shimamoto, K. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00232.x · Cited by 41
Comparison of different definitions of the metabolic syndrome
Sandhofer, A., Iglseder, B., Paulweber, B., Ebenbichler, C. F., & Patsch, J. R. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01751.x · Cited by 41
Diamanti‐Kandarakis, E., Livadas, S., Kandarakis, S., Margeli, A., & Papassotiriou, I. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0822 · Cited by 41
Free Fatty Acids Increase Androgen Precursorsin Vivo
Mai, K., Bobbert, T., Kullmann, V., Andres, J., Rochlitz, H. J., Osterhoff, M. A., Weickert, M. O., Bähr, V., Möhlig, M., Pfeiffer, A. F. H., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2069 · Cited by 41
Selective imidazoline agonist moxonidine in obese hypertensive patients
Sanjuliani, A. F., de Abreu, V. G., & Francischetti, E. A. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00951.x · Cited by 41
Savastano, S., Valentino, R., Somma, C. D., Orio, F., Pivonello, C., Passaretti, F., Brancato, V., Formisano, P., Colao, A., Bèguinot, F., et al. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-84 · Cited by 41
土山, 奈., Takamura, T., Ando, H., Sakurai, M., Shimizu, A., Kato, K., Kurita, S., & Kaneko, S. (2007) · Diabetes Care · doi:10.2337/dc07-0066 · Cited by 41
Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients
Lee, S. W., Park, G. H., Lee, S. W., Song, J. H., Hong, K. C., & Kim, M.-J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm204 · Cited by 40
Engeli, S., Utz, W., Haufe, S., Lamounier‐Zepter, V., Pofahl, M., Traber, J., Janke, J., Luft, F. C., Boschmann, M., Schulz‐Menger, J., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-303735 · Cited by 41
Contribution of Serum Leptin to Metabolic Syndrome in Obese and Nonobese Subjects
Esteghamati, A., Noshad, S., Khalilzadeh, O., Morteza, A., Nazeri, A., Meysamie, A., Esteghamati, A., & Nakhjavani, M. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.05.005 · Cited by 41
Vivodtzev, I., Decorte, N., Wuyam, B., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-0584 · Cited by 41
Pruneta‐Deloche, V., Sassolas, A., Dallinga‐Thie, G. M., Berthézène, F., Ponsin, G., & Moulin, P. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300435-jlr200 · Cited by 41
The Relationship between Hemoglobin Levels and Endothelial Functions in Diabetes Mellitus
Sönmez, A., Yılmaz, M. İ., Sağlam, M., Kılıç, S., Eyileten, T., Üçkaya, G., Çağlar, K., Oğuz, Y., Vural, A., Yenicesu, M., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05080709 · Cited by 41
Meshkani, R., Taghikhani, M., Al‐Kateb, H., Larijani, B. A., Khatami, S., Sidiropoulos, K. G., Hegele, R. A., & Adeli, K. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.088146 · Cited by 41
Yoon, J. W., Kang, S. M., Vassy, J. L., et al. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00185.x · Cited by 41
Hu, C., Zhang, R., Wang, C., Ma, X., Wang, C., Fang, Q., Bao, Y., Xiang, K., & Jia, W. (2008) · Diabetologia · doi:10.1007/s00125-008-1241-3 · Cited by 41
Younsi, M. O., Quilliot, D., Al-Makdissy, N., Delbachian, I., Drouin, P., Donner, M., & Ziegler, O. (2002) · Metabolism · doi:10.1053/meta.2002.35184 · Cited by 44
High ghrelin and obestatin levels and low risk of developing fatty liver
Gutiérrez-Grobe, Y., Villalobos-Blasquez, I., Sánchez-Lara, K., et al. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31679-5 · Cited by 41
Ostan, R., Monti, D., Mari, D., Arosio, B., Gentilini, D., Ferri, E., Passarino, G., Rango, F. D., D’Aquila, P., Mariotti, S., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly194 · Cited by 42
Chan, L. C. K., Ware, R. S., Kesting, J. B., Marczak, M., Good, D. M., & Shaw, J. T. E. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.04.012 · Cited by 40
The total antioxidant capacity of the diet is an independent predictor of plasma β-carotene
Valtueña, S., Rio, D. D., Pellegrini, N., Ardigò, D., Franzini, L., Salvatore, S., Piatti, P. M., Riso, P., Zavaroni, I., & Brighenti, F. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602485 · Cited by 41
Fredriksson, J., Carlsson, E., Orho‐Melander, M., Groop, L., & Ridderstråle, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803138 · Cited by 41
Clinical pharmacological aspects of growth hormone administration
Laursen, T. (2003) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2003.10.001 · Cited by 43
Sympathetic-leptin relationship in obesity: effect of weight loss
Quilliot, D., Böhme, P., Zannad, F. M., & Ziegler, O. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.020 · Cited by 41
Gibney, J., Healy, M. L., Stolinski, M., Bowes, S. B., Pentecost, C., Breen, L., McMillan, C., Russell-Jones, D. L., Sönksen, P. H., & Umpleby, A. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020540 · Cited by 41
Porreca, E., Febbo, C. D., Fusco, L., Moretta, V., Nisio, M. D., & Cuccurullo, F. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.09.022 · Cited by 41
Acute regulation of adiponectin by free fatty acids
BERNSTEIN, E., Koutkia, P., Ljungquist, K. L., Breu, J. J., Hron, B. M., & Grinspoon, S. K. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.023 · Cited by 41
The prevalence of insulin resistance in nondiabetic nonobese patients with chronic kidney disease
Şit, D., Kadiroğlu, A. K., Kayabaşı, H., et al. (2006) · Advances in Therapy · doi:10.1007/bf02850219 · Cited by 41
Ohnishi, H., Saitoh, S., Takagi, S., Ohata, J., Takeuchi, H., Isobe, T., Katoh, N., Chiba, Y., Fujiwara, T., Akasaka, H., et al. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00381.x · Cited by 41
López‐Bermejo, A., Fernández‐Real, J. M., Garrido, E., Rovira, R., Brichs, R., Genaro, P. D. S., Bach, C., Cabrero, D., Kihara, S., Funahashi, T., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02120.x · Cited by 41
Detection of insulin resistance in Turkish adults: a hospital‐based study
Gökçel, A., Baltalı, M., Tarım, E., Bagis, T., Gümürdülü, Y., Karakose, H., Yalcin, F., Akbaba, M., & Guvener, N. D. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00253.x · Cited by 39
Halperin, F., Beckman, J. A., Patti, M., Trujillo, M. E., Garvin, M., Creager, M. A., Scherer, P. E., & Goldfine, A. B. (2005) · Diabetologia · doi:10.1007/s00125-005-1901-5 · Cited by 40
GENDER DIFFERENCE IN THE RELATIONSHIPS AMONG HYPERLEPTINEMIA, HYPERINSULINEMIA, AND HYPERTENSION
Takizawa, H., Ura, N., Saitoh, S., Wang, L., Higashiura, K., Takagi, S., Takada, M., Togashi, N., Nakano, M., Hayashi, Y., et al. (2001) · Clinical and Experimental Hypertension · doi:10.1081/ceh-100102673 · Cited by 41
Serrano‐Ríos, M. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)73455-6 · Cited by 42
Meier, J. J., Nauck, M. A., Siepmann, N., Greulich, M., Holst, J. J., Deacon, C. F., Schmidt, W. E., & Gallwitz, B. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00327-5 · Cited by 41
Chuang, L., Hsiung, C. A., Chen, Y.-D., et al. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100255 · Cited by 41
Hirose, H., Saito, I., Kawabe, H., & Saruta, T. (2003) · Hypertension Research · doi:10.1291/hypres.26.795 · Cited by 41
Moravcová, K., Karbanová, M., Bretschneider, M. P., Sovová, M., Ožana, J., & Sovová, E. (2022) · Nutrients · doi:10.3390/nu14102005 · Cited by 37
Simonson, G. D., & Kendall, D. M. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200512000-00002 · Cited by 38
Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity
Santini, S., Vionnet, N., Pasquier, J., Gonzalez‐Rodriguez, E., Fraga, M., Pitteloud, N., & Favre, L. (2023) · Obesity · doi:10.1002/oby.23596 · Cited by 39
Resting Metabolic Rate after Endurance Exercise Training
LEE, M.-G., SEDLOCK, D. A., FLYNN, M. G., & KAMIMORI, G. H. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31819bd617 · Cited by 40
Kusaka, I., Nagasaka, S., Horie, H., & Ishibashi, S. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00857.x · Cited by 40
Decreased Insulin Clearance in Individuals with Elevated 1-h Post-Load Plasma Glucose Levels
Marini, M. A., Frontoni, S., Succurro, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077440 · Cited by 40
Irandoost, P., Alamdari, N. M., Saidpour, A., Shidfar, F., Roshanravan, N., Jafarabadi, M. A., Farsi, F., Hanjani, N. A., & Vafa, M. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13493 · Cited by 40
de Hoogh, I. M., Winters, B., Nieman, K. M., Bijlsma, S., Krone, T., van den Broek, T. J., Anderson, B. D., Caspers, M. P. M., Anthony, J. C., & Wopereis, S. (2021) · Nutrients · doi:10.3390/nu13061763 · Cited by 40
Batrakoulis, A., Jamurtas, A. Z., Draganidis, D., Georgakouli, K., Tsimeas, P. D., Poulios, A., Syrou, N. F., Deli, C. K., Παπανικολάου, Κ., Tournis, S., et al. (2021) · Antioxidants · doi:10.3390/antiox10101601 · Cited by 41
Zamarrón, E., Oriol, A. J., García‐Sánchez, A., Díaz-Cambriles, T., Alonso‐Fernández, A., Lores, V., Mediano, O., Troncoso, M. F., Cabello, S., Morales, E., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1091oc · Cited by 40
Kerr, A. G., Andersson, D. P., Dahlman, I. A., Rydén, M., & Arner, P. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319227 · Cited by 44
Atherosclerosis and Insulin Resistance: Is There a Link Between Them?
Brie, A. D., Christodorescu, R., Popescu, R., Adam, O., Tîrziu, A., & Brie, D. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061291 · Cited by 50
Brd2 Gene Disruption Causes “Metabolically Healthy” Obesity
Wang, F., Deeney, J. T., & Denis, G. V. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00003-1 · Cited by 41
Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin
Gustafsson, S., Lind, L., Söderberg, S., Zilmer, M., Hulthe, J., & Ingelsson, E. (2013) · Obesity · doi:10.1002/oby.20097 · Cited by 40
Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes
Aziz, M., Sidelmann, J. J., Faber, J. O., Wissing, M. L., Naver, K. V., Mikkelsen, A.-L., Nilas, L., & Skouby, S. O. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12706 · Cited by 40
Hassing, H. C., Surendran, R. P., Derudas, B., Verrijken, A., Francque, S., Mooij, H. L., Moens, S. J. B., Hart, L. M. ‘., Nijpels, G., Dekker, J. M., et al. (2013) · Obesity · doi:10.1002/oby.20682 · Cited by 41
Firouzi, S., Barakatun-Nisak, M. Y., & Azmi, K. N. (2015) · Europe PMC (PubMed Central) · Cited by 40
Evaluation of circulating betatrophin levels in gestational diabetes mellitus
Erol, O. Ö., Elli̇dağ, H. Y., Ayık, H., Özel, M. K., Derbent, A. U., & Yılmaz, N. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1056142 · Cited by 40
Castro, M. C., Francini, F., Gagliardino, J. J., & Massa, M. L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.005 · Cited by 40
Hosseinzadeh‐Attar, M. J., Golpaie, A., Janani, L., & Derakhshanian, H. (2013) · Obesity Facts · doi:10.1159/000351162 · Cited by 40
Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation
Nagaraja, P., Ravindran, V. K., Morris‐Stiff, G. J., & Baboolal, K. (2012) · Transplant International · doi:10.1111/tri.12026 · Cited by 38
Guasti, L., Marino, F., Cosentino, M., Cimpanelli, M., Maio, R. C., Klersy, C., Crespi, C., Restelli, D., Simoni, C., Franzetti, I., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000251903.62804.77 · Cited by 40
Kim, K. (2009) · European Journal of Applied Physiology · doi:10.1007/s00421-008-0973-6 · Cited by 40
El-Halawaty, S., Rizk, A., Kamal, M., AboulHassan, M., Al-Sawah, H., Noah, O., & Al-Inany, H. G. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60379-3 · Cited by 41
Assessment of insulin action on carbohydrate metabolism: physiological and non-physiological methods
Dube, S., Errázuriz, I., Cobelli, C., Basu, R., & Basu, A. (2013) · Diabetic Medicine · doi:10.1111/dme.12189 · Cited by 34
Pozzato, C., Radaelli, G., Dall’Asta, C., et al. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31817b6e10 · Cited by 40
Namvaran, F., Azarpira, N., Rahimi‐Moghaddam, P., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.158 · Cited by 40
Liao, Q., Shi, D., Zheng, W., Xu, X., & Ying-hao, Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.024 · Cited by 40
Plasma apelin levels in subjects with nonalcoholic fatty liver disease
Erçin, C. N., Doğru, T., Tapan, S., Kara, M., Haymana, C., Karadurmuş, N., Karslıoğlu, Y., & Açıkel, C. (2010) · Metabolism · doi:10.1016/j.metabol.2009.10.019 · Cited by 40
Racial Differences in the Association of Insulin Resistance With Stroke Risk
Howard, G., Wagenknecht, L. E., Kernan, W. N., Cushman, M., Thacker, E. L., Judd, S. E., Howard, V. J., & D, B. M. K. M. (2014) · Stroke · doi:10.1161/strokeaha.114.005306 · Cited by 40
Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia
Stepan, H., Kley, K., Hindricks, J., Kralisch, S., Jank, A., Schaarschmidt, W., Schrey-Petersen, S., Ebert, T., Lössner, U., Kratzsch, J., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.02.019 · Cited by 40
Pollin, T. I., Jablonski, K. A., McAteer, J. B., Saxena, R., Kathiresan, S., Kahn, S. E., Goldberg, R. B., Altshuler, D., & Florez, J. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2324 · Cited by 40
Ball, G. D. C., Ambler, K. A., Keaschuk, R. A., Rosychuk, R. J., Holt, N. L., Spence, J. C., Jetha, M. M., Sharma, A. M., & Newton, A. S. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-114 · Cited by 41
Nguyen, N. B., Naik, V., & Speer, M. Y. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.06.007 · Cited by 40
Veilleux, A., Blouin, K., Rhéaume, C., Daris, M., Marette, A., & Tchernof, A. (2009) · Metabolism · doi:10.1016/j.metabol.2008.12.007 · Cited by 40
Saunders, T. J., Tremblay, M. S., Després, J., Bouchard, C., Tremblay, A., & Chaput, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054225 · Cited by 40
Kim, K. M., Lim, S. K., Choi, S. H., Kim, J. H., Shin, C. S., Park, K. S., & Jang, H. C. (2014) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2014.06.001 · Cited by 41
Petta, S., Macaluso, F. S., Barcellona, M. R., Cammà, C., Cabibi, D., Marco, V. D., & Craxı̀, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051165 · Cited by 40
Liu, S.-C., Chien, K., Wang, C., Chen, W.-C., & Cleunghen, C.-H. (2013) · Endocrine Practice · doi:10.4158/ep13148.or · Cited by 40
Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study
Hosseinpanah, F., Barzin, M., Erfani, H., Serahati, S., Tehrani, F. R., & Azizi, F. (2013) · Clinical Endocrinology · doi:10.1111/cen.12287 · Cited by 40
Parim, B., Nemani, H., Meriga, B., Pothana, S., & Sajjalaguddam, R. R. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.980585 · Cited by 40
Cortisol, energy intake, and food frequency in overweight/obese women
Vicennati, V., Pasqui, F., Cavazza, C., Garelli, S., Casadio, E., Dalmazi, G. D., Pagotto, U., & Pasquali, R. (2010) · Nutrition · doi:10.1016/j.nut.2010.07.016 · Cited by 40
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
